A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma
Conditions
Multiple Myeloma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Monash Medical Centre, Clayton, Australia
St Vincents Hospital Melbourne, Fitzroy, Australia
Peter MacCallum Cancer Centre, Melbourne, Australia
Calvary Mater Newcastle Hospital, Waratah, Australia
Wollongong Hospital, Wollongong, Australia
Carmel Medical Center, Haifa, Israel
Hadassah Medical Center, Jerusalem, Israel
Sheba Medical Center, Ramat Gan, Israel
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
VU Medisch Centrum, Amsterdam, Netherlands
Universitair Medisch Centrum Groningen, Groningen, Netherlands
UMC Utrecht, Utrecht, Netherlands
Hosp. Clinic de Barcelona, Barcelona, Spain
Hosp Clinico Univ de Salamanca, Salamanca, Spain
Study leads
Janssen Research & Development, LLC Clinical Trial
Study Director
Janssen Research & Development, LLC